Literature DB >> 23374978

Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.

Donatella Marazziti1, Stefano Baroni, Michela Picchetti, Armando Piccinni, Marina Carlini, Elena Vatteroni, Valentina Falaschi, Amedeo Lombardi, Liliana Dell'Osso.   

Abstract

Data on the specific effects of sex on pharmacokinetics, as well as tolerability, safety, and efficacy of psychotropic medications are still meager, mainly because only recently sex-related issues have attracted a certain degree of interest within the pharmacological domain. Therefore, with the present study, we aimed to provide a comprehensive review of the literature on this topic, through careful MEDLINE and PubMed searches of the years 1990-2012. Generally, data on pharmacokinetics are more consistent and numerous than those on pharmacodynamics. Sex-related differences have been reported for several parameters that influence pharmacokinetics, such as gastric acidity, intestinal motility, body weight and composition, blood volume, liver enzymes (mainly the cytochrome P450), or renal excretion, which may alter plasma drug levels. Sex-related peculiarities may also account for a different sensitivity of men and women to side effects and toxicity of psychotropic drugs. Further, some differences in drug response, mainly to antipsychotics and antidepressants, have been described. Further studies are, however, necessary to explore more thoroughly the impact of sex on the pharmacokinetics and pharmacodynamics of psychotropic drugs, in order to reach the most appropriate and tailored prescription for each patient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374978     DOI: 10.1017/S1092852912001010

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  18 in total

1.  Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMI.

Authors:  H P Sigurdsson; G Hefner; N Ben-Omar; A Köstlbacher; K Wenzel-Seifert; C Hiemke; E Haen
Journal:  J Neural Transm (Vienna)       Date:  2014-09-26       Impact factor: 3.575

Review 2.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

3.  A research agenda for gender and substance use disorders in the emergency department.

Authors:  Esther K Choo; Gillian Beauchamp; Francesca L Beaudoin; Edward Bernstein; Judith Bernstein; Steven L Bernstein; Kerryann B Broderick; Robert D Cannon; Gail D'Onofrio; Marna R Greenberg; Kathryn Hawk; Rashelle B Hayes; Gabrielle A Jacquet; Melanie J Lippmann; Karin V Rhodes; Susan H Watts; Edwin D Boudreaux
Journal:  Acad Emerg Med       Date:  2014-12-01       Impact factor: 3.451

4.  ABCB1 variants and sex affect serotonin transporter occupancy in the brain.

Authors:  Leo R Silberbauer; Lucas Rischka; Chrysoula Vraka; Annette M Hartmann; Godber Mathis Godbersen; Cécile Philippe; Daniel Pacher; Lukas Nics; Manfred Klöbl; Jakob Unterholzner; Thomas Stimpfl; Wolfgang Wadsak; Andreas Hahn; Marcus Hacker; Dan Rujescu; Siegfried Kasper; Rupert Lanzenberger; Gregor Gryglewski
Journal:  Mol Psychiatry       Date:  2022-09-07       Impact factor: 13.437

5.  Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with Rifampicin.

Authors:  Aida N Kawuma; Roeland E Wasmann; Kelly E Dooley; Marta Boffito; Gary Maartens; Paolo Denti
Journal:  Antimicrob Agents Chemother       Date:  2022-05-23       Impact factor: 5.938

Review 6.  Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women.

Authors:  Flavia Franconi; Ilaria Campesi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 7.  Sex differences in antidepressant efficacy.

Authors:  Tara A LeGates; Mark D Kvarta; Scott M Thompson
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

8.  Childhood trauma mediates repetitive transcranial magnetic stimulation efficacy in major depressive disorder.

Authors:  Yu-Ting Hu; Xi-Wen Hu; Jin-Fang Han; Jian-Feng Zhang; Ying-Ying Wang; Annemarie Wolff; Sara Tremblay; Zhong-Lin Tan; Georg Northoff
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-06-12       Impact factor: 5.270

9.  Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).

Authors:  E Besi; D R Boniface; R Cregg; J M Zakrzewska
Journal:  J Headache Pain       Date:  2015-09-03       Impact factor: 7.277

Review 10.  Individual differences and the characterization of animal models of psychopathology: a strong challenge and a good opportunity.

Authors:  Antonio Armario; Roser Nadal
Journal:  Front Pharmacol       Date:  2013-11-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.